Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin.
McHutchison JG, Poynard T, Esteban-Mur R, Davis GL, Goodman ZD, Harvey J, Ling MH, Garaud JJ, Albrecht JK, Patel K, Dienstag JL, Morgan T; International Hepatitis Interventional Therapy Group. McHutchison JG, et al. Among authors: harvey j. Hepatology. 2002 Mar;35(3):688-93. doi: 10.1053/jhep.2002.31870. Hepatology. 2002. PMID: 11870385
Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.
McHutchison JG, Patel K, Schiff ER, Gitlin N, Mur RE, Everson GT, Carithers RL Jr, Davis GL, Marcellin P, Shiffman ML, Harvey J, Albrecht JK; International Hepatitis Interventional Therapy Group. McHutchison JG, et al. Among authors: harvey j. Aliment Pharmacol Ther. 2008 Mar 1;27(5):422-32. doi: 10.1111/j.1365-2036.2007.03590.x. Epub 2007 Dec 11. Aliment Pharmacol Ther. 2008. PMID: 18081733 Clinical Trial.
Impact of weight-based ribavirin with peginterferon alfa-2b in African Americans with hepatitis C virus genotype 1.
Jacobson IM, Brown RS Jr, McCone J, Black M, Albert C, Dragutsky MS, Siddiqui FA, Hargrave T, Kwo PY, Lambiase L, Galler GW, Araya V, Freilich B, Harvey J, Griffel LH, Brass CA; WIN-R Study Group. Jacobson IM, et al. Among authors: harvey j. Hepatology. 2007 Oct;46(4):982-90. doi: 10.1002/hep.21670. Hepatology. 2007. PMID: 17894323 Clinical Trial.
A randomised trial to compare the pharmacokinetic, pharmacodynamic, and antiviral effects of peginterferon alfa-2b and peginterferon alfa-2a in patients with chronic hepatitis C (COMPARE).
Silva M, Poo J, Wagner F, Jackson M, Cutler D, Grace M, Bordens R, Cullen C, Harvey J, Laughlin M. Silva M, et al. Among authors: harvey j. J Hepatol. 2006 Aug;45(2):204-13. doi: 10.1016/j.jhep.2006.03.008. Epub 2006 Apr 18. J Hepatol. 2006. PMID: 16780997 Clinical Trial.
Challenges in determining the global burden of non-malignant central nervous system tumors: an analysis of international incidence and mortality data sources.
Dean F, Henrikson H, Xu R, Farah H, Lu D, Harvey J, Fu W, Pritchett N, Bhakta N, Moreira DC, Qaddoumi I, Girardi F, Vos T, Naghavi M, Finlay JL, Force LM. Dean F, et al. Among authors: harvey j. Neuro Oncol. 2025 Jan 15:noaf006. doi: 10.1093/neuonc/noaf006. Online ahead of print. Neuro Oncol. 2025. PMID: 39812442
In vivo base editing extends lifespan of a humanized mouse model of prion disease.
An M, Davis JR, Levy JM, Serack FE, Harvey JW, Brauer PP, Pirtle CP, Berríos KN, Newby GA, Yeh WH, Kamath N, Mortberg M, Lian Y, Howard M, DeSouza-Lenz K, Guzman K, Thai A, Graffam S, Coffey AA, Frei J, Pierce SE, Safar JG, Deverman BE, Minikel EV, Vallabh SM, Liu DR. An M, et al. Among authors: harvey jw. Nat Med. 2025 Jan 14. doi: 10.1038/s41591-024-03466-w. Online ahead of print. Nat Med. 2025. PMID: 39810005
Four-electron reduction of benzene by a samarium(II)-alkyl without the addition of external reducing agents.
Richardson GM, Rajeshkumar T, Burke FM, Cameron SA, Nicholls BD, Harvey JE, Keyzers RA, Butler T, Granville S, Liu L, Langley J, Lim LF, Cox N, Chilton NF, Hicks J, Davis NJLK, Maron L, Anker MD. Richardson GM, et al. Among authors: harvey je. Nat Chem. 2025 Jan;17(1):20-28. doi: 10.1038/s41557-024-01688-6. Epub 2025 Jan 3. Nat Chem. 2025. PMID: 39754016
Natural and Semisynthetic Immunomodulatory Luakuliide Labdane Diterpenoids.
Ramirez-Garcia JL, Grant EK, Salamat A, Anker MD, Cameron SA, Kelly M, Matoto SV, Barber JM, Northcote PT, Williams-Spence JW, La Flamme AC, Harvey JE, Singh AJ, Keyzers RA. Ramirez-Garcia JL, et al. Among authors: harvey je. J Nat Prod. 2024 Dec 23. doi: 10.1021/acs.jnatprod.4c01218. Online ahead of print. J Nat Prod. 2024. PMID: 39714955
3,293 results